Skip to main content
logo
BioPharma Credit PLC (LON:BPCR)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.9780
+0.0060 (0.62%)
Sep 25, 2026, 9:08 AM GMT

BioPharma Credit Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Revenue
131.4157.75150.03135.74218.17103.88
Revenue
131.4157.75150.03135.74218.17103.88
Revenue Growth
-15.04%5.14%10.53%-37.78%110.02%-5.58%
Gross Profit
131.4157.75150.03135.74218.17103.88
Selling, General & Admin
24.0428.0327.7227.2835.7918.95
Other Operating Expenses
-0.14-0.140.1300.04-0.05
Operating Expenses
23.9127.927.8527.2835.8318.9
Operating Income
107.49129.85122.18108.46182.3484.98
Interest Expense
-0-----
Currency Exchange Gain (Loss)
0.010.04-0-0.01-0.03-0.02
Pretax Income
107.49129.89122.18108.45182.3184.96
Net Income
107.49129.89122.18108.45182.3184.96
Net Income to Common
107.49129.89122.18108.45182.3184.96
Net Income Growth
-12.70%6.31%12.66%-40.51%114.59%-4.69%
Shares Outstanding (Basic)
1,1281,1401,2221,3091,3641,374
Shares Outstanding (Diluted)
1,1281,1401,2221,3091,3641,374
Shares Change
-3.91%-6.77%-6.65%-4.00%-0.72%-0.00%
EPS (Basic)
0.100.110.100.080.130.06
EPS (Diluted)
0.100.110.100.080.130.06
EPS Growth
-9.14%14.03%20.68%-38.03%116.14%-4.68%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.0700.0700.0700.0700.0700.070
Dividend Growth
100.00%0%0%0%0%0%
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
81.80%82.31%81.44%79.90%83.58%81.80%
Profit Margin
81.81%82.34%81.44%79.90%83.56%81.79%
EBIT
107.49129.85122.18108.46182.3484.98
EBIT Margin
81.80%82.31%81.44%79.90%83.58%81.80%
Revenue as Reported
131.4157.78150.03135.73218.14103.86